                         SEQUENCE LISTING

<110>  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
       UNIVERSITY OF CALABRIA
 
<120>  SERPININ, SERPININ VARIANTS, AND CARDIOVASCULAR DISEASE

<130>  709395

<150>  US 61/427,243
<151>  2010-12-27

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  Homo sapiens

<400>  1

Pro Glu Asp Gln Glu Leu Glu Ser Leu Ser Ala Ile Glu Ala Glu Leu 
1               5                   10                  15      


Glu Lys Val Ala His Gln Leu Gln Ala Leu 
            20                  25      


<210>  2
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is blocked

<400>  2

Xaa Glu Leu Glu Ser Leu Ser Ala Ile Glu Ala Glu Leu Glu Lys Val 
1               5                   10                  15      


Ala His Gln Leu Gln Ala Leu 
            20              


<210>  3
<211>  23
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is PYRROLIDONE CARBOXYLIC ACID

<400>  3

Xaa Glu Leu Glu Ser Leu Ser Ala Ile Glu Ala Glu Leu Glu Lys Val 
1               5                   10                  15      


Ala His Gln Leu Gln Ala Leu 
            20              


<210>  4
<211>  29
<212>  PRT
<213>  Homo sapiens

<400>  4

Ala Glu Asp Gln Glu Leu Glu Ser Leu Ser Ala Ile Glu Ala Glu Leu 
1               5                   10                  15      


Glu Lys Val Ala His Gln Leu Gln Ala Leu Arg Arg Gly 
            20                  25                  


